Neurocrine Biosciences Inc NBIX:NASDAQ

Last Price$96.93NASDAQ Closing Price as of 4:00PM ET 6/28/22

Today's Change-3.00(3.00%)
Bid (Size)$81.00 (5)
Ask (Size)$101.00 (2)
Day Low / High$96.41 - 99.95
Volume625.0 K
  • Latest Stories
  • Commentary and Analysis
Research Alert: CFRA Keeps Hold Opinion On Shares Of Neurocrine Biosciences
1:55PM ET 6/10/2022 MT Newswires

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as...

Jefferies Assumes Neurocrine Biosciences at Buy with $112 Price Target
10:15AM ET 6/06/2022 MT Newswires

Neurocrine Biosciences (NBIX) has an average rating of outperform and price targets ranging from $75 to $150, according to analysts polled by Capital IQ....

Neurocrine Biosciences to Repurchase $179.4 Million of Convertible Notes
3:04AM ET 5/25/2022 MT Newswires

Neurocrine Biosciences (NBIX) entered into privately negotiated transactions to repurchase about $179.4 million of its existing 2.25% convertible senior...

Neurocrine Biosciences Gets FDA's Orphan Drug Designation for Experimental Huntington Disease Drug
3:42AM ET 5/13/2022 MT Newswires

Neurocrine Biosciences (NBIX) said late Thursday the US Food and Drug Administration granted an orphan drug designation to valbenazine for the potential...

Insider Sell: Neurocrine Biosciences
5:41PM ET 5/11/2022 MT Newswires

Richard F Pops, Director, on May 09, 2022, sold 15,000 shares in Neurocrine Biosciences (NBIX) for $1,144,463. Following the Form 4 filing with the SEC,...

Earnings Reaction History: Neurocrine Biosciences, 33.3% Follow-Through Indicator, 4.8% Sensitive
12:39PM ET 5/04/2022 MT Newswires

Expected Earnings Release: 05/04/2022, After-hours Avg. Extended-Hours Dollar Volume: $11,976,203 Neurocrine Biosciences (NBIX) is due to issue its...

--Wedbush Adjusts Price Target for Neurocrine Biosciences to $103 From $104, Maintains Outperform Rating
11:45AM ET 5/04/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Neurocrine Biosciences Q1 Non-GAAP EPS Drops, Revenue Rises; Reiterates 2022 Ingrezza Sales Guidance
8:38AM ET 5/04/2022 MT Newswires

Neurocrine Biosciences (NBIX) reported Wednesday Q1 non-GAAP earnings of $0.30 per share, compared with $0.50 a year earlier. Analysts polled by Capital IQ...

-- Earnings Flash (NBIX) NEUROCRINE BIOSCIENCES Posts Q1 EPS $0.30
7:38AM ET 5/04/2022 MT Newswires


-- Earnings Flash (NBIX) NEUROCRINE BIOSCIENCES Posts Q1 Revenue $310.6M, vs. Street Est of $304.1M
7:37AM ET 5/04/2022 MT Newswires